insights_auto
Outlook: 83.3% bullish·0.0% bearish
Go to analysischevron_right
HALO:NASDAQ
Halozyme Therapeutics, Inc.
$110.42
arrow_upward
+0.53%(+0.58) 1D
$111.35
arrow_upward
+0.84% (+0.93)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 7 analysts giving stock ratings to HALO in the past 3 months
Buy
Buy
5
Hold
2
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for HALO in the last 3 months.
Highest
Current $110.42
$115.00 (+4.15%)
Average
$100.14 (-9.31%)
Lowest
$78.00 (-29.36%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Jessica Fye J.P. Morgan | Hold | Reiterated | $78.00 | -29.4% | 10/08/2026 |
David Risinger Leerink Partners | Buy | Maintained | $110.00 | -0.4% | 10/07/2026 |
Mitchell Kapoor H.C. Wainwright | Buy | Reiterated | $115.00 | +4.1% | 10/07/2026 |
Sean Laaman Morgan Stanley | Buy | Reiterated | $105.00 | -4.9% | 08/07/2026 |
Jason Butler Citizens JMP | Buy | Maintained | $93.00 | -15.8% | 08/07/2026 |
Mohit Bansal Wells Fargo | Hold | Reiterated | $95.00 | -14% | 08/07/2026 |
Brendan Smith TD Cowen | Buy | Reiterated | $105.00 | -4.9% | 08/07/2026 |
Corinne Johnson Goldman Sachs | Sell | Maintained | $57.00 | -48.4% | 06/14/2026 |
Unknown Analyst J.P. Morgan | Hold | Maintained | $70.00 | -36.6% | 05/20/2026 |
Robert Wasserman Benchmark Co. | Buy | Maintained | $90.00 | -18.5% | 02/19/2026 |